Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 9.92K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -2.11M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -11.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -11.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -50.00% |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 18.60M | 52W Low Chg | - |
| Insider Own | - | ROA | -60.95% | Shares Float | - | Beta | 7.27 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00010 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 5,337 | Target Price | - |
| Oper. Margin | - | Earnings Date | - | Volume | 700 | Change | 0.00% |
About PROUROCARE MEDICAL INC
ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.